The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
Open accessAbstract
Congenital melanocytic nevi (CMN) can be associated with neurological abnormalities and an increased risk of melanoma. Mutations in NRAS, BRAF, and Tp53 have been described in individual CMN samples; however, their role in the pathogenesis of multiple CMN within the same subject and development of associated features has not been clear. We hypothesized that a single postzygotic mutation in NRAS could be responsible for multiple CMN in the same individual, as well as for melanocytic and nonmelanocytic central nervous system (CNS) lesions. From 15 patients, 55 samples with multiple CMN were sequenced after site-directed mutagenesis and enzymatic digestion of the wild-type allele. Oncogenic missense mutations in codon 61 of NRAS were found in affected neurological and cutaneous tissues of 12 out of 15 patients, but were absent from unaffected tissues and blood, consistent with NRAS mutation mosaicism. In 10 patients, the mutation was consistently c.181C>A, p.Q61K, and in 2 patients c.182A>G, p.Q61R. All 11 non-melanocytic and melanocytic CNS samples from 5 patients were mutation positive, despite NRAS rarely being reported as mutated in CNS tumors. Loss of heterozygosity was associated with the onset of melanoma in two cases, implying a multistep progression to malignancy. These results suggest that single postzygotic NRAS mutations are responsible for multiple CMN and associated neurological lesions in the majority of cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome
Lindhurst, M. J., Sapp, J. C., Teer, J. K., Johnston, J. J., Finn, E. M., Peters, K., Turner, J., Cannons, J. L., Bick, D., Blakemore, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104017 · Cited by 903
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
Tidyman, W. E., & Rauen, K. A. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.001 · Cited by 780
RAS Interaction with PI3K: More Than Just Another Effector Pathway
Castellano, E., & Downward, J. (2011) · Genes & Cancer · doi:10.1177/1947601911408079 · Cited by 762 · cited 4×
“E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s NRAS is an extensively characterised oncogene involved in the control of key cell signaling pathways (Castellano and Downward, 2011; Pylayeva-Gupta et al., 2011).”
InfluentialAdjei, A. A., Cohen, R. B., Franklin, W., Morris, C., Wilson, D., Molina, J. R., Hanson, L. J., Gore, L., Chow, L., Leong, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4956 · Cited by 570
Happle, R. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)80249-9 · Cited by 552
Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome
Kurek, K. C., Luks, V. L., Ayturk, U. M., Alomari, A. I., Fishman, S. J., Spencer, S. A., Mulliken, J. B., Bowen, M. E., Yamamoto, G. L., Kozakewich, H. P. W., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.006 · Cited by 532
Congenital Melanocytic Nevi Frequently Harbor NRAS Mutations but no BRAF Mutations
Bauer, J., Curtin, J. A., Pinkel, D., & Bastian, B. C. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700490 · Cited by 351
MC1R Germline Variants Confer Risk for BRAF -Mutant Melanoma
Landi, M. T., Bauer, J., Pfeiffer, R. M., Elder, D. E., Hulley, B., Minghetti, P., Calista, D., Kanetsky, P. A., Pinkel, D., & Bastian, B. C. (2006) · Science · doi:10.1126/science.1127515 · Cited by 346
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome
Groesser, L., Herschberger, E., Ruetten, A., Ruivenkamp, C., Lopriore, E., Zutt, M., Langmann, T., Singer, S., Klingseisen, L., Schneider-Brachert, W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2316 · Cited by 335
A restricted spectrum of NRAS mutations causes Noonan syndrome
Cirstea, I. C., Kutsche, K., Dvorsky, R., Gremer, L., Carta, C., Horn, D., Roberts, A. E., Lepri, F., Merbitz-Zahradnik, T., König, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.497 · Cited by 315
Genetic Changes in Neoplasms Arising in Congenital Melanocytic Nevi
Bastian, B. C., Xiong, J., Frieden, I. J., Williams, M. L., Chou, P., Busam, K., Pinkel, D., & LeBoit, P. E. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64393-3 · Cited by 241
Kumar, R., Angelini, S., Snellman, E., & Hemminki, K. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22225.x · Cited by 229
NAKATO, N., Takata, M., Takayanagi, S., Takashima, S., Lin, J., Murata, H., Fujimoto, A., Hatta, N., & Saida, T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700366 · Cited by 150
Oncogenic NRAS Cooperates with p53 Loss to Generate Melanoma in Zebrafish
Dovey, M. C., White, R. M., & Zon, L. I. (2009) · Zebrafish · doi:10.1089/zeb.2009.0606 · Cited by 149
Papp, T., Pemsel, H., Zimmermann, R., Bastrop, R., Weiss, D. G., & Schiffmann, D. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.8.610 · Cited by 144
Kinsler, V. A., Birley, J., & Atherton, D. J. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08849.x · Cited by 134
Self-citationClinical manifestations of mutations in RAS and related intracellular signal transduction factors
Zenker, M. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834881dd · Cited by 96
Hacker, E., Hayward, N. K., Dumenil, T. D., James, M. R., & Whiteman, D. C. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.182 · Cited by 93
Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis
Ramaswamy, V., Delaney, H., Haque, S. S., Marghoob, A. A., & Khakoo, Y. (2012) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2012.04275.x · Cited by 91
Dessars, B., Raeve, L. E. D., Morandini, R., Lefort, A., Housni, H. E., Ghanem, G., den Eynde, B. J. V., Ma, W., Roseeuw, D. I., Vassart, G., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.203 · Cited by 85
Dessars, B., Raeve, L. E. D., Housni, H. E., Debouck, C., Sidon, P. J., Morandini, R., Roseeuw, D. I., Ghanem, G., Vassart, G., & Heimann, P. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700725 · Cited by 84
Noonan syndrome gain-of-function mutations inNRAScause zebrafish gastrulation defects
Runtuwene, V., van Eekelen, M., Overvoorde, J., Rehmann, H., Yntema, H. G., Nillesen, W. M., van Haeringen, A., van der Burgt, I., Burgering, B. M. T., & den Hertog, J. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007112 · Cited by 73
Kinsler, V. A., Abu-Amero, S. N., Budd, P. S., Jackson, I. J., Ring, S. M., Northstone, K., Atherton, D. J., Bulstrode, N., Stanier, P., Hennekam, R. C. M., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.95 · Cited by 67
Self-citationMutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi
Papp, T., Schipper, H., Kumar, K., Schiffmann, D., & Zimmermann, R. (2005) · Melanoma Research · doi:10.1097/00008390-200510000-00008 · Cited by 64
The face in congenital melanocytic nevus syndrome
Kinsler, V. A., Shaw, A. C., Merks, J. H. M., & Hennekam, R. C. M. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34217 · Cited by 62
Self-citationProtection against UVR Involves MC1R-Mediated Non-Pigmentary and Pigmentary Mechanisms In Vivo
Robinson, S., Dixon, S. V., August, S., Diffey, B. L., Wakamatsu, K., Ito, S., Friedmann, P. S., & Healy, E. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.48 · Cited by 51
Self-citationDifferential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis
Ferguson, B., Muller, H. K., Handoko, H. Y., Khosrotehrani, K., Beermann, F., Hacker, E., Soyer, H. P., Bosenberg, M., & Walker, G. J. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00752.x · Cited by 45
Association between the Germline MC1R Variants and Somatic BRAF/NRAS Mutations in Melanoma Tumors
Scherer, D., Rachakonda, P. S., Angelini, S., Mehnert, F., Sucker, A., Egberts, F., Hauschild, A., Hemminki, K., Schadendorf, D., & Kumar, R. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.242 · Cited by 37
Familial clustering of giant congenital melanocytic nevi
de Wijn, R. S., Zaal, L. H., Hennekam, R. C. M., & van der Horst, C. M. A. M. (2009) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2009.02.090 · Cited by 36
Lack of BRAFV600E Mutations in Giant Congenital Melanocytic Nevi in a Chinese Population
Wu, D., Wang, M., Wang, X., Yin, N., Song, T., Li, H., Yu, J., Wang, D.-M., & Zhao, Z. (2011) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e3181fb5bc7 · Cited by 36
Cited by
The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Bastian, B. C. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104658 · Cited by 513
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
Al-Olabi, L., Polubothu, S., Dowsett, K., Andrews, K. A., Stadnik, P., Joseph, A. P., Knox, R., Pittman, A., Clark, G., Baird, W., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98589 · Cited by 292
Self-citation
Metadata
- Authors
- Kinsler, V. A., Thomas, A. C., Ishida, M., Bulstrode, N. W., Loughlin, S., Hing, S., Chalker, J., McKenzie, K., Abu-Amero, S., Slater, O., Chanudet, E., Palmer, R., Morrogh, D., Stanier, P., Healy, E., Sebire, N. J., & Moore, G. E.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 133
- Issue
- 9
- Pages
- 2229-2236
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2095112712
- Cited by
- 348
- References
- 32
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.